Loading clinical trials...
Loading clinical trials...
Chronic inflammatory demyelinating polyradiculoneuropathy (PIDC) is an acquired dysimmune polyneuropathy whose prevalence is estimated to be between 1 to 4 per 100,000 depending on the study, with an ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Fondation Hôpital Saint-Joseph
NCT07264426 · Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP, and more
NCT06747351 · Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
NCT06538064 · Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
NCT06502015 · Autoimmune Diseases of the Nervous System, Neuromyelitis Optica Spectrum Disorder, and more
NCT04561557 · Autoimmune Diseases, Autoimmune Diseases of the Nervous System, and more
Groupe Hospitalier Paris Saint-Joseph
Paris
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions